Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic Romik GhoshSenthilnathan MohanasundaramShalini Menon Current Opinion Open access 05 July 2021 Pages: 197 - 202
The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic Allan TranTheodore J. Witek Jr Leading Article 28 August 2021 Pages: 203 - 213
Biosimilar Uptake: The Importance of Healthcare Provider Education Sonia Tadjalli OskoueiAndrew R. Kusmierczyk Leading Article Open access 22 August 2021 Pages: 215 - 224
Clinical Quality in Cancer Research: Strategy to Assess Data Integrity of Germline Variants Inferred from Tumor-Only Testing Sequencing Data Timothé MénardDonato RoloBjörn Koneswarakantha Leading Article 26 August 2021 Pages: 225 - 233
Challenges Faced by the Biopharmaceutical Industry in the Development and Marketing Authorization of Biosimilar Medicines in BRICS-TM Countries: An Exploratory Study Hasumati RahalkarAlan SheppardSam Salek Original Research Article Open access 22 July 2021 Pages: 235 - 251
Evaluation of Drug Lags in Development Initiation, New Drug Application and Approval Between Japan and the USA and the Impact of Local Versus Multi-regional Clinical Trials Satoshi UshijimaNaoki MatsumaruKatsura Tsukamoto Original Research Article 22 July 2021 Pages: 253 - 260
Major Pharmaceutical Conferences and Courses: October to November 2021 Update 08 July 2021 Pages: 261 - 265